Eckert & Ziegler

Company Snapshot

Founded: 1992
Entity Type: Public
Employees: 1,085
Region: Germany
Revenue: $320.2 Millions
Revenue Year: 2024
Headquarter: Berlin, Germany
Key Geographics: North America, Europe, Asia-Pacific, Other Countries
Corporate Address: Robert-Rössle-Street 10 D-13125 Berlin Germany Tel. +49-3094-10840 www.ezag.com

Company Overview

Eckert & Ziegler SE is a global manufacturer of isotope technology components for medical, scientific, and industrial applications. The company manages its business in two reportable segments: Medical and Isotope Products. The Medical segment offers nuclear medicine and radiotherapy products. The Isotope Products segment manufactures isotope technology components for imaging processes, scientific applications, quality assurance, and industrial measurement purposes. The company also offers contract development and manufacturing services for the nuclear medicine industry.

Eckert & Ziegler offers a comprehensive portfolio of nuclear medicine products (radiopharmaceuticals and radionuclides) for research, development, and drug product manufacturing. The product portfolio includes gallium-68 generators, pharmaceutical yttrium-90 chloride, and a wide range of radiochemicals such as Lutetium-177 (n.c.a.) or Actinium-225.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Eckert & Ziegler In Reports

Radiopharmaceuticals: Technologies and Global Markets

BCC Research Report: Dive into radiopharmaceuticals market report includes global revenue ($ Million) for base year data of 2023 and estimated data for the forecast period 2024 through 2029.

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

BCC Research Market Report says radiopharmaceuticals and therapeutics market should reach $28.5 billion by 2026 from $18.2 billion in 2021 at a CAGR of 9.4%.

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Explore the global market for radiotherapy, radiopharmaceuticals & nuclear medicines and examine the future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and...

Company's Business Segments

  • Isotope Products : This segment manufactures and distributes standards and radiation sources for medical and industrial purposes.
  • Medical : This segment offers a variety of radiopharmaceutical services under GMP and cGMP conditions all from a single source.
  • Other : It includes the items of the holding company Eckert & Ziegler SE as well as those of the Pentixapharm Group up until the time of the spin-off.

Applications/End User Industries

  • Healthcare
  • Medical
  • Industrial
  • Scientific Research
AI Sentiment